Discovery of Protective Genetic Variants to Develop Disease Modifying Therapeutics for ALS

Time: 2:00 pm
day: Conference Day One Track A PM

Details:

  • Unpacking the role of genetic heterogeneity in ALS
  • Shifting perspective – protective genetic variants in non-neuronal genes that impact disease progression and survival
  • Development of targeted disease modifying therapeutics

Speakers: